Attenuated physical exercise capacity in smokers compared with non-smokers after coronary angioplasty despite similar luminal diameters

European Heart Journal

Volumn 19, Issue 5, 1998, Pages 737-741

  Jorgensen B ^a,b   Endresen, K ^a   Forfang, K ^a   Simonsen, S ^a   Thaulow, E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angioplasty; Coronary artery disease; Exercise capacity; Exercise testing; Smoking

Indexed keywords

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AMLODIPINE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EXERCISE TEST; HUMANS; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; SMOKING; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032080508     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0836     Document Type: Article

References (22)

1. [1] Vandormael MG, Chaitman B, Ischinger T et al. Immediate and short-term benefit of multilesion coronary angioplasty: influence of degree of revascularization. J Am Coll Cardiol 1985; 6: 983-91.
2. [2] Berger E, Williams DO, Reinert S, Most A. Sustained efficacy of percutaneous transluminal coronary angioplasty. Am Heart J 1986; 111: 233-6.
3. [3] Cowley MJ, Vetrovec GW, Wolfgang TC. Efficacy of percutaneous transluminal coronary angioplasty: technique, patient selection, salutary results, limitations and complications. Am Heart J 1981; 101: 272-80.
4. [4] Rosing DR, van Raden MJ, Mincemoyer RM et al. Exercise, electrocardiographic and functional responses after percutaneous transluminal coronary angioplasty. Am J Cardiol 1984; 53: 36C-41C.
5. [5] Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy middle-aged Norwegian men. N Engl J Med 1993; 328: 533-7.
6. [6] Sidney S, Sternfeld B, Gidding SS et al. Cigarette smoking and submaximal exercixe test duration in a biracial population of young adults: the CARDIA study. Med Sci Sports Exerc 1993; 25: 911-16.
7. [7] Leon AS, Jacobs Jr DR, DeBacker G, Taylor HL. Relationship of physical characteristics and life habits to treadmill exercise capacity. Am J Epidemiol 1981; 113: 653-60.
8. [8] Thaulow E, Jøgensen B. Clinical promise of calcium antagonists in the angioplasty patient. Eur Heart J 1997; 18 (Suppl B): B21-B26.
9. [9] Sandvik L, Erikssen G, Thaulow E. Long term effects of smoking on physical fitness and lung function: a longitudinal study of 1393 middle aged Norwegian men for seven years. BMJ 1995; 311: 715-8.
10. [10] Serruys PW, Foley DP, De Feyter PJ. Quantitative Coronary Angiography in Clinical Practice. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1994.
11. [11] Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326: 10-6.
12. [12] Hampton JR, Henderson RA, Julian DG et al. Coronary angioplasty versus coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial. Lancet 1993; 341: 573-80.
13. [13] Ernst MPG, Hillebrand FA, Klein B, Ascoop CA, van Tellingen C, Plokker HWM. The value of exercise tests in the follow-up of patients who underwent transluminal coronary angioplasty. Int J Cardiol 1985; 7: 267-79.
14. [14] Serruys PW, Luijten HE, Beatt KJ et al. Incidence of restenosis after successful angioplasty: a time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, or 4 month. Circulation 1988; 77: 361-71.
15. [15] Nobuyoshi M, Kimura T, Hideyuki N et al. Restenosis after successful percutaneous coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-23.
16. [16] Crow RS, Rautaharju PM, Prineas RJ et al. Risk factors, exercise fitness and electrocardiographic response to exercise in 12 866 men at high risk of symptomatic coronary disease. Am J Cardiol 1986; 57: 1075-83.
17. [17] Gordon DJ, Leon AS, Ekelund LG et al. Smoking, physical activity, and other predictors of endurance and heart rate response to exercise in asymptomatic hypercholesterolemic men. The lipid research clinics coronary primary prevention trial. Am J Epidemiol 1987; 125: 587-600.
18. [18] The health consequence of smoking. Chronic obstructive lung disease. A report of the surgeon general. Department of Health and Human Services, Public Health Service, Office on Smoking and Health, DHHS publication 1984; No(PHS) 84-50205.
19. 2max. J Appl Physiol 1989; 66: 2491-5.
20. [20] Kiowski W, Linder L, Stoschitzky K et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994; 90: 27-34.
21. [21] McVeigh GE, Lemay L, Morgan D, Cohn JN. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996; 78: 668-72.
22. [22] Chang J, Atwood JE, Froelicher V. Prognostic impact of myocardial ischemia. J Am Coll Cardiol 1994; 23: 225-8.